News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GVK BIO Launches A New "Brand" For A Renewed Customer Focus In The Clinical Development Service Offering


7/17/2014 11:19:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MUMBAI, India--(BUSINESS WIRE)--GVK Biosciences (GVK BIO), Asia’s leading Discovery Research and Development organization today unveiled a new brand CLINOGENT in the Clinical Development industry. CLINOGENT provides end to end Clinical Development services. From offering bioequivalence studies for generic pharma and late phase patient based clinical studies for research based companies, CLINOGENT brings exceptional expertise in delivering solutions to complex data analysis and medical communication problems to customers the world over. CLINOGENT will endeavor to provide innovative solutions to all the Clinical and scientific challenges that their customers face in the business.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES